Healthcare provider profile · identity verified

Anna Ramirez - Chernikova, M.D.

Family Practice · CAPE CORAL, FL · NPI 1356660476

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	600	191
Losartan Potassium	Losartan Potassium	450	141
Levothyroxine Sodium	Levothyroxine Sodium	424	143
Lisinopril	Lisinopril	406	128
Amlodipine Besylate	Amlodipine Besylate	400	136
Rosuvastatin Calcium	Rosuvastatin Calcium	326	104
Metformin Hcl	Metformin Hcl	290	100
Omeprazole	Omeprazole	272	87
Gabapentin	Gabapentin	244	84
Pantoprazole Sodium	Pantoprazole Sodium	215	72
Simvastatin	Simvastatin	214	68
Fluticasone Propionate	Fluticasone Propionate	178	81
Alprazolam	Alprazolam	176	43
Metoprolol Succinate	Metoprolol Succinate	168	57
Metoprolol Tartrate	Metoprolol Tartrate	166	52
Ozempic	Semaglutide	154	32
Famotidine	Famotidine	149	54
Jardiance	Empagliflozin	143	33
Albuterol Sulfate Hfa	Albuterol Sulfate	136	56
Escitalopram Oxalate	Escitalopram Oxalate	133	41
Pravastatin Sodium	Pravastatin Sodium	133	45
Sertraline Hcl	Sertraline Hcl	132	49
Diclofenac Sodium	Diclofenac Sodium	126	42
Montelukast Sodium	Montelukast Sodium	126	40
Hydrochlorothiazide	Hydrochlorothiazide	116	39
Meloxicam	Meloxicam	104	39
Mounjaro	Tirzepatide	102	21
Alendronate Sodium	Alendronate Sodium	99	34
Duloxetine Hcl	Duloxetine Hcl	99	25
Trazodone Hcl	Trazodone Hcl	95	39
Clonazepam	Clonazepam	94	19
Zolpidem Tartrate	Zolpidem Tartrate	92	21
Vitamin D2	Ergocalciferol (Vitamin D2)	83	22
Allopurinol	Allopurinol	82	29
Furosemide	Furosemide	81	26
Olmesartan Medoxomil	Olmesartan Medoxomil	81	28
Lorazepam	Lorazepam	78	19
Tamsulosin Hcl	Tamsulosin Hcl	77	26
Torsemide	Torsemide	77	25
Clopidogrel	Clopidogrel Bisulfate	75	25
Buspirone Hcl	Buspirone Hcl	74	23
Baclofen	Baclofen	71	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	66	23
Carvedilol	Carvedilol	64	19
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	64	22
Trulicity	Dulaglutide	63	suppressed
Lovastatin	Lovastatin	60	16
Potassium Chloride	Potassium Chloride	59	20
Glipizide Er	Glipizide	58	23
Synthroid	Levothyroxine Sodium	58	18
Venlafaxine Hcl Er	Venlafaxine Hcl	58	13
Metformin Hcl Er	Metformin Hcl	53	21
Celecoxib	Celecoxib	52	13
Fenofibrate	Fenofibrate Nanocrystallized	50	19
Atenolol	Atenolol	49	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	23
Meclizine Hcl	Meclizine Hcl	47	16
Methylprednisolone	Methylprednisolone	46	44
Hydralazine Hcl	Hydralazine Hcl	45	18
Diazepam	Diazepam	44	14
Warfarin Sodium	Warfarin Sodium	43	12
Ezetimibe	Ezetimibe	42	16
Triamcinolone Acetonide	Triamcinolone Acetonide	42	28
Azelastine Hcl	Azelastine Hcl	40	22
Cephalexin	Cephalexin	39	34
Citalopram Hbr	Citalopram Hydrobromide	39	14
Fluoxetine Hcl	Fluoxetine Hcl	39	suppressed
Ibuprofen	Ibuprofen	39	16
Valsartan	Valsartan	37	19
Hydroxyzine Hcl	Hydroxyzine Hcl	36	11
Tizanidine Hcl	Tizanidine Hcl	36	20
Pregabalin	Pregabalin	35	suppressed
Eliquis	Apixaban	34	14
Ondansetron Hcl	Ondansetron Hcl	34	18
Alcohol Pads	Alcohol Antiseptic Pads	33	suppressed
Estradiol	Estradiol	33	14
Mometasone Furoate	Mometasone Furoate	33	suppressed
Tramadol Hcl	Tramadol Hcl	33	17
Bisoprolol Fumarate	Bisoprolol Fumarate	32	suppressed
Bupropion Xl	Bupropion Hcl	32	12
Irbesartan	Irbesartan	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	14
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Eszopiclone	Eszopiclone	31	12
Farxiga	Dapagliflozin Propanediol	31	suppressed
Ondansetron Odt	Ondansetron	30	12
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	30	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	29	suppressed
Nifedipine Er	Nifedipine	29	11
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Temazepam	Temazepam	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Enalapril Maleate	Enalapril Maleate	28	11
Spironolactone	Spironolactone	28	suppressed
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Lactulose	Lactulose	26	suppressed
Nitroglycerin	Nitroglycerin	26	17
Prolia	Denosumab	26	19
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	22
Sucralfate	Sucralfate	24	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Methocarbamol	Methocarbamol	23	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	14
Glimepiride	Glimepiride	22	suppressed
Hydrocortisone	Hydrocortisone	22	11
Januvia	Sitagliptin Phosphate	22	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	22	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Mupirocin	Mupirocin	21	17
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Vascepa	Icosapent Ethyl	20	suppressed
Clobetasol Propionate	Clobetasol Propionate	19	11
Glipizide	Glipizide	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Finasteride	Finasteride	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Topiramate	Topiramate	18	suppressed
Latanoprost	Latanoprost	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Nystatin	Nystatin	17	12
Scopolamine	Scopolamine	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Dexlansoprazole Dr	Dexlansoprazole	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	16
Lidocaine	Lidocaine	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Timolol Maleate	Timolol Maleate	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Cefdinir	Cefdinir	15	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Linzess	Linaclotide	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Ramipril	Ramipril	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Colchicine	Colchicine	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Indapamide	Indapamide	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Praluent Pen	Alirocumab	12	suppressed
Prednisone	Prednisone	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Naproxen	Naproxen	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error